Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. (2019)
Attributed to:
How does ERK1/2-dependent phosphorylation target BimEL to the proteasome?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-12409-w
PubMed Identifier: 31727888
Publication URI: http://europepmc.org/abstract/MED/31727888
Type: Journal Article/Review
Volume: 10
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723